Automated description from the Alliance of Genome Resources
Predicted to have collagen binding activity; heparin binding activity; and peptidase activator activity. Involved in cellular response to leukemia inhibitory factor. Localizes to the collagen-containing extracellular matrix. Is expressed in several structures, including branchial arch; jaw; limb; nasal cavity epithelium; and skeleton. Orthologous to human PCOLCE2 (procollagen C-endopeptidase enhancer 2).